Fatima Dhalla
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Fatima Dhalla
Fatima Dhalla is recorded as CFO at Endovia Health Sciences, Inc. (EDVA). Endovia Health Sciences, Inc. reported in an 8-K filed January 30, 2024 that Fatima Dhalla resigned as Interim Chief Financial Officer, effective January 19, 2024. Endovia Health Sciences, Inc. reported in an 8-K filed October 2, 2023 that Fatima Dhalla was appointed Interim Chief Financial Officer, effective September 28, 2023. The proxy statement of Endovia Health Sciences, Inc. reports total compensation of $55,950 for Fatima Dhalla in fiscal 2023, including a base salary of $55,950.
“In connection with Ms. McLaughlin’s appointment as Chief Financial Officer, former Interim Chief Financial Officer, Fatima Dhalla, has resigned as the Interim Chief Financial Officer of the Company, effective January 19, 2024.”
“Effective September 28, 2023, the Board of Directors of the Company appointed Fatima Dhalla as the Interim Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-09-28–present
-
2023-09-28–2024-01-19
-
Start not stated–2024-01-19
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Endovia Health Sciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Brady Cobb CEO, Board Member
- Robert Nistico Chairman, Board Member
- Dean Huge CFO
- Julius Ivancsits CFO
- Martin Scott CFO
- Stacy McLaughlin CFO
- William "Bill" Devereux CFO
- Michael Bondurant COO
- Candace Crawford Board Member
- Dr. John Paglia Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Endovia Health Sciences, Inc. (EDVA) | Interim CFO | $55,950 | $55,950 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.